Vaccines in the era of genomics: the pneumococcal challenge
about
A Brief Review of Computer-Assisted Approaches to Rational Design of Peptide VaccinesGlycotherapy: new advances inspire a reemergence of glycans in medicinePneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg ADiscovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodiesPenicillin resistance and serotype distribution of Streptococcus pneumoniae in Ghanaian children less than six years of age.T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.Comparative genomics of the bacterial genus Streptococcus illuminates evolutionary implications of species groupsBMX: a tool for computing bacterial phyletic composition from orthologous maps.An evaluation of emerging vaccines for childhood pneumococcal pneumonia.Diversity of Pneumolysin and Pneumococcal Histidine Triad Protein D of Streptococcus pneumoniae Isolated from Invasive Diseases in Korean Children.Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children.Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumoniaNovel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal ColonizationAntibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.Role of bioinformatics in the development of new antibacterial therapy.Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.Developing antibacterial vaccines in genomics and proteomics era.Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein AAnimal models of Streptococcus pneumoniae diseasePneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).Discovery and design of carbohydrate-based therapeutics.Genome-based bacterial vaccines: current state and future outlook.Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates.Towards Identifying Protective B-Cell Epitopes: The PspA Story.Identification of proteins in Streptococcus pneumoniae by reverse vaccinology and genetic diversity of these proteins in clinical isolates.The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance.Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related.Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016.Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.
P2860
Q24261117-113958A9-96AF-4BB5-9422-107605CC971CQ27027997-BEEB04FB-AD60-4CB4-BE2A-F35F5C1C5601Q28472283-56704611-A58E-4736-A446-1E8A4166ECEFQ33312893-3BA1FF12-2E57-4E0A-BF03-DBAD3C0DD54FQ33589297-FD81F1C0-4B47-470B-93FC-AA423704FD14Q34312495-88544E2F-3588-4D8F-A48E-14A83050C454Q35092077-E0357707-1027-482B-B755-3301744C5E58Q35197598-1E66CDF5-2271-445E-A165-BB2FD2EFE637Q35574415-5C51A0FB-AE63-4D0E-A853-C1729639023FQ35595931-78DC1F72-E8E0-4E0E-88C3-CD4A5E199601Q35739683-EEF0760E-22D5-4E71-B53E-5ED99F9F6F6EQ35915846-302E86D1-E58C-45BB-AF9F-FF96132AF0BEQ36163091-130FED4F-8263-4136-9745-E95FEA148B3FQ36953778-0EC8542F-B8AC-4EED-8848-FC4FC0857BC1Q37002290-57B937B4-AEDF-4766-BA9A-6E0E8D0E0080Q37033022-AEB2D053-919E-4879-8F2D-FE100B58BB1EQ37077624-44DC414F-000A-42BE-BDFC-AC9D514FAC25Q37119456-BEA41E37-E5D8-4D2E-A872-CDA29A9DAD58Q37132297-469C86B3-FCAC-4E50-854C-6840EA203177Q37252358-F24EC2C0-C4B6-4926-A9F3-BA79796795B2Q37293669-83234F1B-5319-4955-8A87-9007E5A1A385Q37316015-A0447F7A-ED70-45A1-8415-298F19BFE597Q37483596-9108350F-FC3F-4E66-8A4E-ACB827CA8019Q38029137-15B77500-0343-480B-B84A-818FC2733079Q38099207-63FEFACF-5061-469E-9D90-BCE2880135DBQ38140041-A9018A36-C0C6-4495-8B3D-3B65A10476DCQ38781789-7B7269D0-1AC4-4B4E-8248-F999F569E7F8Q39089994-E9791D5A-292C-4182-BD44-9A5A992F6726Q40332317-9D3F0DCE-44D7-4779-A608-F3B6BCFD953EQ41315974-CA2114BD-DACF-4CDD-8A55-0840B4AD6ABDQ44419720-7D4D14B0-B459-425C-8026-508353001064Q45709889-B9BD872A-9AA7-4565-90B5-D0DD26BB6337Q50199957-0A0243E9-E7A6-4E4C-A41E-A2EB01FBE53BQ51416013-D9204641-EBD8-48F1-8D9B-D42317EC3CFC
P2860
Vaccines in the era of genomics: the pneumococcal challenge
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Vaccines in the era of genomics: the pneumococcal challenge
@ast
Vaccines in the era of genomics: the pneumococcal challenge
@en
Vaccines in the era of genomics: the pneumococcal challenge
@nl
type
label
Vaccines in the era of genomics: the pneumococcal challenge
@ast
Vaccines in the era of genomics: the pneumococcal challenge
@en
Vaccines in the era of genomics: the pneumococcal challenge
@nl
prefLabel
Vaccines in the era of genomics: the pneumococcal challenge
@ast
Vaccines in the era of genomics: the pneumococcal challenge
@en
Vaccines in the era of genomics: the pneumococcal challenge
@nl
P3181
P1433
P1476
Vaccines in the era of genomics: the pneumococcal challenge
@en
P2093
Michèle Anne Barocchi
Stefano Censini
P304
P3181
P356
10.1016/J.VACCINE.2007.01.065
P407
P577
2007-04-20T00:00:00Z